SciQuest gives customers full control over chemical inventory with latest ERM upgrade
Used by eight out of the top 10 global pharmaceutical companies, ERM’s newest version includes the industry’s first triple federated search engine.
SciQuest, a leading provider of spend management solutions delivering value beyond savings, has released the latest version of Enterprise Reagent Manager (ERM), the only chemical inventory management software that gives researchers and scientists full and efficient control over research inventory from sourcing and purchase through tracking and disposal.
Used by eight out of the top 10 global pharmaceutical companies, ERM’s newest version includes the industry’s first triple federated search engine, complete with real-time material availability check from suppliers, which allows search across all internal and external sources simultaneously. Through this robust capability, users can now search chemicals by supplier, chemical structure or text description to better meet their research needs.
With near instant startup, ERM 9 is up to 90 percent faster than previous versions. The dynamic and responsive user interface contains one-click tiles for quick navigation to important tasks and status icons that remain with use and display user actions, like items adding to a shopping cart or requesting a container for use from inventory. With the most modern UI that SciQuest has ever developed, ERM is adapted for the tablets and workstations most widely used in today’s research environments.
In addition to the federated search, the ERM 9 upgrade includes the following features:
Held Cart: Allows administrators to control purchases of high cost and/or hazardous materials from non-authorized personnel
“Since ERM closely integrates with procurement, pharmaceutical manufacturers can control complex inventories with reduced general spend and disposal costs, optimized inventory use, and increased regulatory compliance while managing the risks associated with hazardous materials,” said Stephen Wiehe, president and CEO of SciQuest. “With the first and only triple federated search, ERM is so powerful that it even allows the user to start taking action or look up specific information on displayed results, while continuing to receive results for more applicable chemicals or building block compounds.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance